Colorectal cancer regarded as one of the most widespread malignant tumor in the world. It is considered the second leading death factor among people in some developed countries. Colorectal cancer comprises several distinct histological types including adenocarcinoma which forms 85%-95% of all colorectal cancer cases. Pathogenesis of colorectal cancer is a multistep process characterized by involvement of many genetic alterations, including p53. The aim of this study is to detect the expression of p53 protein in colorectal carcinoma and to show its relationship with some clinicopathological features including age, gender, histological types, histological grades and staging. 
Introduction
ancer of the large bowel continues to be one of the major public health problems, ranking as the second or third cause of cancer related death in many western countries with more than one million new cases diagnosed each year 1, 2 .
It is the second leading cause of cancer death in the United State [3] [4] [5] . In 2004, in the U.S. there were 145,083 new cases of colorectal cancer (CRC), and 53,580 people died of the disease 6 . There are several etiologic determinants of CRC, C since multiple steps are involved in its occurrence. Several genetic mutation have been detected, and exogenous factors interact for the development of the acquired ones 7 . Risk factors that have been identified include a personal history of colorectal cancer or adenomas, family history of colon cancer or adenomas, inherited colorectal cancer syndromes, and long standing inflammatory bowel disease. There is convincing evidence that nutrition affects colorectal carcinogenesis, also low levels of physical activity, obesity, smoking and excessive alcohol intake, may play a role in colon cancer development 8, 9 . Approximately 80% of colorectal carcinomas occur sporadically, whereas 20% appear to have a genetic basis 9, 10 . However, the recognized familial colorectal cancer syndromes-FAP and HNPCC account for much less than one third of inherited colorectal cancer, leaving the additional heritable component of this disease unexplained 11 . Genetic changes inactivating tumor suppressor genes (APC, DCC, and p53), activating oncogenes (k-ras), and inactivating DNA mismatch repair genes are implicated in the development of CRC 12 . The aim of this study is to detect the expression of p53 protein in colorectal cancer and its relationships to the clinicopathologic factors including age, gender, histological types, histological grading, and staging of the disease. (4) (5) (6) . Relationships between p53 Expression and Clinicopathological Features: Age Distribution and p53 Expression: Result of our study revealed that 5cases(45.5%) of the score (0) were in the age group 40-49 years. While most of the cases in score (3+) were in age groups 40-49 years and 50-59 years. Statistically there is no significant relationship between p53 and age distribution as shown in table III. Gender and p53 Expression: In both males and females most of the cases (42.9%) were males, 7(36.8%) females in score (0), followed by 7(33.3%) males, 5 (26.3%) females in score (3+), 3(14.3%) males, 5 (26.3%) females in score (2+), and 2(9.5%) males, 2(10.5%) females in Score (1+) as shown in figure (6) . Statistically there is no significant relationship between p53 expression and gender. Histological Types and p53 Expression: P53 over expression was more frequently seen in adenocarcinoma 12(35.3%) of cases in score (3+), followed by 6(17.6%) and 4(11.8%) of cases in the Score (2+) and (1+) respectively while in mucinous carcinoma only 1(25.0%) of cases in score (2+) and the remaining 3(75.0%) were in score (0). In signet-ring cell carcinoma 1(50.0%) of cases in score (0) and 1(50,0%) was in score (2+) as shown in 
Materials and methods

Discussion
Mutations of P53 are the most frequently detected genetic alteration in human cancer which is found in more than 50% of all human cancers [13] [14] [15] . Mutation of the p53 gene alters the conformation of the nuclear protein product, which can inactivate wild-type p53 protein16.The longer half life of the mutant p53 protein results in the accumulation of this phosphoprotein in the nuclei, facilitating its detection by immunohistochemical analysis 17 . Elevated expression of the p53 protein or mutational inactivation of the p53 gene has been shown in various human malignant tumors including carcinoma of colon and rectum 18, 19 , breast 20 , prostate 21 , lung 22 , stomach 16 , thyroid 23 , and liver 24 . In colorectal carcinoma the occurrence of p53 mutation is variable among different series and has been found in 50% to 70% of cases 13, 18 . In the present study, p53 expression by IHC techniques detected in 24 (60%) out of the 40 analyzed colorectal carcinoma cases. This result is consistent with other studies 17, 25, 26 . Clinicopathological variables: In this study, the age of patients was 20-80 years with most of the cases being in the 5th decade of life and a median age of 47.5 years. Which occurs in a younger age group than other reported studies done by Ahsan et al 27 and Neagoes et al 28 who reported that most of the CRC cases are in the 6th and 7th decades of life. Regarding gender in this study 52.5% of patients were males and 47.5% were females. This is consistent with other studies that showed nearly equal gender distribution 29, 30 . In the current study shows that adenocarcinoma accounts for 85% of cases, followed by mucinous (10%) and signet-ring cell carcinoma (5%). This is consistent with a study done by Georgescu et al. they reported the same results (85% of cases were adenocarcinoma followed by mucinous carcinoma in 10% of cases, and signet ring carcinoma in 5% of cases) 17 In the present study, there was no significant relationships between p53 and age, or gender and is consistent with other studies that found no relationships between these variables 13, 33 . While the study done by Slattery et al. detected significant relationships between age and gender and p53 expression which is inconsistent with the results of our study 34 . In the present study, there was no significant relationship between p53 expression and histological types but higher frequency of p53 positive cell has been shown in adenocarcinoma than mucinous and signet ring cell carcinoma. This result is consistent with the study done by Kim et al. and Georgesco et al. who found higher frequency of p53 positive cells for adenocarcinom than mucinous and signet ring cell carcinoma but no significant relationship between p53 and histological types 33, 17 , while Asaad et al. found significant relationship between p53 and histological types 26 , and there is no significant relationship between p53 expression and histological grading which is consistent with the studies done by Georgescu et al. and Asaad et al 17, 26 . In the present study there is no relationship between staging and p53 expression which is consistent with the results of study done by Demirbas et al. who found no significant relationship between p53 and staging but inconsistent with the result of study done by Jackson et al. who found significant relationship between p53 and staging 35, 36 . The role of p53 as a prognostic factor is till now controversial. In some studies p53 was regarded as a bad prognostic factor 37 , while in other studies the accumulation of p53 protein might have a favorable prognostic value 38 . In conclusion, Sulaimania region showed an unusually young CRC patient age. The median age of 47.5 years was almost 25 years younger than CRC patients in the west. Evidence of p53 mutation are found in the majority of CRC in our clinical population suggesting that chromosomal instability is responsible for most of colorectal carcinomas. No relationship could be found between p53 expression and the clinicopathological variables of age, gender, histological types, histological grades, and staging. 
